Vaccine under development in the United States Clinical trial started 1 year or more before commercialization or March 17 at 10:50
NIH-National Institutes of Health has announced that a first-stage clinical trial of a new coronavirus vaccine being developed in collaboration with a pharmaceutical company has begun in Washington State on the 16th. President Trump emphasized the results, stating that it was "the fastest vaccine development in history," but it is expected to take more than a year to put it to practical use.
NIH has begun developing a new coronavirus vaccine in mid-January in collaboration with American pharmaceutical company Moderna. The trial vaccine was completed late last month, and the NIH announced on Tuesday that the first clinical trial of the vaccine has begun at a healthcare facility in Seattle, Washington.
The trial divides 45 healthy adults into groups, each group receiving two different doses of the vaccine, spaced approximately 28 days apart. People who receive the vaccine are regularly tested at medical institutions for one year to check their safety and to see if they are working.
Approximately two months after the start of development, clinical trials begin at an unprecedented rate for vaccine development, and President Trump stressed at a press conference on June 16 that "it was the earliest vaccine development in history." did.
However, about the time of practical application, Dr. Anthony Fouch, who leads the new type of coronavirus countermeasures at NIH, says that it will take one to one and a half years to actually confirm the safety and effect and start immunization in general. Is.